Albon Tablet
Albon is an FDA-approved preparation containing Albon, for veterinary use. Available by prescription.
Veterinarians most commonly consider Albon® when a patient is presented with respiratory, genitourinary or gastrointestinal health concerns involving susceptible bacteria. It is also frequently a point of discussion for the management of coccidiosis, a parasitic infection caused by Coccidia. By interfering with the metabolic processes of susceptible microorganisms, your veterinarian can manage the physiological progression of the infection.
At a pharmacological level, sulfadimethoxine acts as a competitive inhibitor of para-aminobenzoic acid (PABA). This inhibition may help reduce the synthesis of bacterial dihydrofolic acid, a precursor essential for the production of folic acid. Since bacteria and certain protozoa must synthesize their own folic acid to produce nucleic acids for DNA replication, the lack of this nutrient may help address the growth and multiplication of the pathogens. This bacteriostatic activity provides the patient's immune system with the opportunity to address the remaining infection. Your veterinarian will determine whether Albon® is appropriate based on the species, weight and the nature of the prescriptions required for your pet's specific clinical presentation.
The actions described here reflect the product's FDA-approved labeling; your veterinarian determines the appropriate use for your animal.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring.
Commonly observed effects of Albon® administration include a temporary decrease in appetite, vomiting or loose stools. Because sulfonamides are primarily excreted by the kidneys, maintaining adequate hydration is a clinical priority; your veterinarian will monitor for signs of kidney health and ensure your pet has constant access to fresh water. In some dogs, sulfonamides have been associated with a decrease in tear production (Keratoconjunctivitis Sicca or "dry eye"). Owners should watch for signs of eye discharge, persistent squinting or unusual skin rashes and contact their veterinarian promptly if these behavioral shifts occur.
This medication is typically used with extra caution or avoided in patients with known severe renal or hepatic impairment, or in those with a history of sulfonamide hypersensitivity. Certain breeds, such as Doberman Pinschers, have been associated with a higher risk of immune-mediated reactions to this class of medication—a factor your veterinarian will weigh when evaluating the approach. Before starting a protocol, ensure your veterinarian has a complete history of all other supplements and medications your pet is receiving, as sulfadimethoxine can interact with certain diuretics and local anesthetics. Your veterinarian is the right person to provide guidance on the necessary duration of use and the appropriate monitoring schedule to ensure the management approach remains suitable for your pet's individual health status.
Yes. Albon® is a prescription antimicrobial medication and can only be dispensed by a licensed pharmacy upon receipt of a valid authorization from a licensed veterinarian. Mixlab verifies all authorizations before any medication is prepared or shipped to your home.
Yes. While Albon® is available as a specific commercial oral suspension and tablet, Mixlab can compound the active ingredient, sulfadimethoxine, into specialized strengths or alternative flavored dosage forms if your veterinarian determines a customized preparation better suits your pet's needs. The decision between a commercial and compounded product rests with the prescribing veterinarian.
Veterinarians most commonly discuss Albon® for the management of coccidiosis, a common intestinal parasite, as well as various bacterial infections of the skin, respiratory tract and urinary system. Its use is determined by a licensed professional based on diagnostic findings and the patient's overall health profile.
Commonly observed responses include digestive upset or a decrease in appetite. More specifically, owners should monitor for signs of "dry eye," such as squinting or thick discharge, and ensure the pet remains well-hydrated throughout the protocol. Any unusual behavioral shifts should be reported to your veterinarian immediately.
